433-7 Buhr T, Länger F, Schlué J, von Wasielewski R, Kreipe H: Histopathologie leukämischer Non-Hodgkin-Lymphome im Knochenmark. Pathologe 2002; 23: 438-47 Buhr T, Länger F, Schlué J, von Wasielewski R
n bei hämatologischen Neoplasien von Wasielewski, Sabine (Dr. med.): Histology and Prognosis in Hodgkins's disease 2000 Baer-Henney, Stefanie (Dr. med.): Seeblaue Histozyten im Knochenmark bei der chronischen
Franklin J, Fischer R, Hübner K, Hansmann ML, Diehl V, Georgii A, von Wasielewski R: Nodular sclerosis Hodgkin's Disease: new grading predicts prognosis in intermediate and advanced stages. Blood 2003; 101(10):
zielt darauf ab, die vorhandene RACOON-Plattform zu nutzen, um die Versorgung von kindlichen Non-Hodgkin-Lymphomen (NHL) zu optimieren. Das NHL ist das vierthäufigste Malignom im Kinder- und Jugendalter
84(4): 298-303 Reich A, Maj J, Schlue J, Kreipe HH , Mazur G: Primary cutaneous peripheral T-cell non-Hodgkin lymphoma, not otherwise specified, with cytotoxic features. Int J Dermatol 2010; 49: 967-969 [Case
sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma. Bone Marrow Transplant 2016; 51(9): 1271-1274 Borlak J, Länger F , Spanel R, Schöndorfer [...] Stiefel M, Klein C, Körholz D, Mauz-Körholz C, Kreipe H , Beier R, Maecker-Kolhoff B: Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated
REUTER C, BRANDIS A, KRAUSS JK: Outcome of surgical decompression of spinal mass lesions in non Hodgkin´ s lymphoma and plasmocytoma. Clinical Neurology and Neurosurgery 115:2476-2481, 2013. HONG B, NAKAMURA [...] inhibitor induced autoimmune central nervous system disorder in patients with metastatic melanoma and Hodgkin lymphoma. Clin Exp Neuroimmunol. (in press) *equal contribution MOEHN N, WATTJES MP, ADAMS O, NAY [...] HENKENBERENS C, FRANZKE A, RAAB P, OSCHLIES I, KLAPPER W, CHRISTIANSEN H (2014). "Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment : Case report and review of the literature."
Health Economics and Health Policy 2013; 11: 509-521 Braun S / Russo L / Zeidler J / Linder R / Hodgkins P. Descriptive comparison of drug treatment–persistent, –nonpersistent, and nondrug treatment patients
Stiefel M, Klein C, Körholz D, Mauz-Körholz C, Kreipe H , Beier R, Maecker-Kolhoff B: Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated
551-6. 2006 Franzke A, Koenecke C, Geffers R, Piao W, Hunger JK, Ganser A, Buer J. (2006). Classical Hodgkin's lymphoma: molecular evidence for specific alterations in circulating T lymphocytes. Tumour Biol